A Double Mutant Heat-Labile Toxin from Escherichia coli, LT(R192G/L211A), Is an Effective Mucosal Adjuvant for Vaccination against Helicobacter pylori Infection

The A Subunit of Escherichia coli Heat-Labile Enterotoxin Functions as a Mucosal Adjuvant and Promotes IgG2a, IgA, and Th17 Responses to Vaccine Antigens

(2012) Elizabeth B. Norton et al.   INFECTION AND IMMUNITY

Th17 Cells Upregulate Polymeric Ig Receptor and Intestinal IgA and Contribute to Intestinal Homeostasis

(2012) Anthony T. Cao et al.   JOURNAL OF IMMUNOLOGY

Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice

(2012) Carl-Fredrik Flach et al.   VACCINE

Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant

(2011) Elizabeth B. Norton et al.   Clinical and Vaccine Immunology

Vaccine-Induced Immunity Against Helicobacter pylori in the Absence of IL-17A

(2011) Elizabeth S. DeLyria et al.   HELICOBACTER

Options for Inactivation, Adjuvant, and Route of Topical Administration of a Killed, Unencapsulated Pneumococcal Whole-Cell Vaccine

(2010) Y.-J. Lu et al.   Clinical and Vaccine Immunology

Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice

(2010) Dorit Becher et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Proinflammatory Cytokine Gene Expression in the Stomach Correlates with Vaccine-Induced Protection againstHelicobacter pyloriInfection in Mice: an Important Role for Interleukin-17 during the Effector Phase

(2010) Carl-Fredrik Flach et al.   INFECTION AND IMMUNITY

Sublingual Immunization Protects against Helicobacter pylori Infection and Induces T and B Cell Responses in the Stomach

(2010) S. Raghavan et al.   INFECTION AND IMMUNITY

Immune Responses toHelicobacter pyloriInfection in Bangladeshi Children during Their First Two Years of Life and the Association between Maternal Antibodies and Onset of Infection

(2010) Taufiqur Rahman Bhuiyan et al.   JOURNAL OF INFECTIOUS DISEASES

A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori

(2010) Carl-Fredrik Flach et al.   VACCINE

CCR7-CCL19/CCL21-Regulated Dendritic Cells Are Responsible for Effectiveness of Sublingual Vaccination

(2009) J.-H. Song et al.   JOURNAL OF IMMUNOLOGY

Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin

(2009) Nancy A. Summerton et al.   VACCINE

Cholera toxin structure, gene regulation and pathophysiological and immunological aspects

(2008) J. Sánchez et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Vaccination of Mice Against H pylori Induces a Strong Th-17 Response and Immunity That Is Neutrophil Dependent

(2008) Elizabeth S. DeLyria et al.   GASTROENTEROLOGY

Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines

(2008) T Aebischer et al.   GUT